Prevnar has potential to be world's best selling drug... what's with the drop in share price?
Don't understand the dip in stock price considering that Prevnar, already a huge success, has the potential to become the best selling drug in the world, conceivably outperforming lipitor. That drug, and others in the pipeline, make PFE a strong buy... what gives?
Anyone with a true appreciation for the Pfizer pipeline and the drugs it currently has on the market WOULD NOT be selling their shares. Thank goodness for the less sophisticated pharmaceutical investor - it just provides those in the know with the opportunity to purchase additional shares at a bargain price.
Agree with you. The drop is an expected reaction to the miss, if only by a penny, of the analyst forcast of income and also the conservative guidance given (better to underpromise and overdeliver...). Don't worry, dip will only be temporary with strong buy back by savy investors.